Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 27 min ago
PreprintCC BY 4.0HAL

Epigenome editing in animal production: a prospective review

Abstract

Epigenome editing is a set of molecular approaches that aims at modifying one or several epigenetics marks in one or a few target genomic regions. It can be used to decipher the causal regulatory mechanisms governing gene expression, to validate putative distal regulatory elements, and to modify gene expression levels. The long term repression or activation of a target gene of interest without altering the DNA sequence of a cell constitutes one of the most promising applications of epigenome editing, including in farm animals. Here we present the main molecular tools currently used to perform epigenome editing in vitro or in vivo: the guidance systems (including CRISPR based), the epigenetic effector domains in use, and the delivery method available in vitro or in vivo. A list of studies reporting in vivo epigenome editing in animals (mostly in mice) is proposed, highlighting methodological choices that have been made by their authors. For example, some approaches require an alteration of the host DNA sequence (i.e. using lentiviral infection), 1 while others let the host genome intact. Some approaches have effects across the whole organism, and even putative inter-generational effects, while other approaches target a single somatic organ. Finally, we list potential applications in farm animal species, ranging from research to commercial solutions. We discuss the implications of the different methodological options, including in terms of economic feasibility and public acceptability.

Related

  1. Beyond DNA—CRISPR technologies for epigenome editing and transcriptional regulation in disease: A scoping review
    Elijah Kolawole Oladipo, Victoria Oluwayemisi Adubiaran, Aanuoluwa Temitayo Iyiola +13
    Clinical and Translational DiscoveryPeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
  2. CasNano: An ultracompact CRISPR-Cas12f with a GC-rich PAM for epigenome editing with therapeutic potential
    Dongkyeong Kim, Chia-Wei Huang, Richard Pan +5
    Molecular therapy. Nucleic acidsPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  3. Programming plant resilience with CRISPR/dCas9 epigenome editing: from proof of concept to crop deployment
    Jacob Wu
    Frontiers in Genome EditingPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  4. Iterative genome editing of Escherichia coli for 3-hydroxypropionic acid production
    Rongming Liu, Liya Liang, Alaksh Choudhury +4
    Metabolic EngineeringPeer-reviewedLicence not stated52 citedMolecular biology & gene regulationHAL
  5. Molecular and cellular mechanisms of muscle–adipose tissue crosstalk driving sarcopenic obesity: an integrative review of human, animal, and in vitro models
    Mahmoud A. Seliem, Mamdouh A. Ragab
    Nutrition & MetabolismPeer-reviewedCC BYFull text6 citedMolecular biology & gene regulationOpenAlex
BibTeX
@misc{kirstetter2026epigenome,
  title = {{Epigenome editing in animal production: a prospective review}},
  author = {Anne-Sophie Kirstetter and Fábio Pértille and Carlos Guerrero-Bosagna and Franck L. B. Meijboom and Guillaume Devailly},
  howpublished = {HAL},
  year = {2026},
  month = oct,
  url = {https://hal.inrae.fr/hal-05410119v4},
  note = {CC BY 4.0},
}
RIS
TY  - UNPB
TI  - Epigenome editing in animal production: a prospective review
AU  - Anne-Sophie Kirstetter
AU  - Fábio Pértille
AU  - Carlos Guerrero-Bosagna
AU  - Franck L. B. Meijboom
AU  - Guillaume Devailly
PY  - 2026
DA  - 2026/10/07
PB  - HAL
UR  - https://hal.inrae.fr/hal-05410119v4
AB  - Epigenome editing is a set of molecular approaches that aims at modifying one or several epigenetics marks in one or a few target genomic regions. It can be used to decipher the causal regulatory mechanisms governing gene expression, to validate putative distal regulatory elements, and to modify gene expression levels. The long term repression or activation of a target gene of interest without altering the DNA sequence of a cell constitutes one of the most promising applications of epigenome editing, including in farm animals. Here we present the main molecular tools currently used to perform epigenome editing in vitro or in vivo: the guidance systems (including CRISPR based), the epigenetic effector domains in use, and the delivery method available in vitro or in vivo. A list of studies reporting in vivo epigenome editing in animals (mostly in mice) is proposed, highlighting methodological choices that have been made by their authors. For example, some approaches require an alteration of the host DNA sequence (i.e. using lentiviral infection), 1 while others let the host genome intact. Some approaches have effects across the whole organism, and even putative inter-generational effects, while other approaches target a single somatic organ. Finally, we list potential applications in farm animal species, ranging from research to commercial solutions. We discuss the implications of the different methodological options, including in terms of economic feasibility and public acceptability.
ER  -